Approval of the first quarter 2022 consolidated financial
reports by the Board of Directors
Date of events
2022/06/13
To which item it meets
paragraph 51
Statement
1.Date of the financial reports reported to or passed by
the board of directors:2022/06/13
2.Date of the financial reports passed by
the audit committee:2022/06/13
3.Date of the financial reports audited and
attested (reviewed) by CPAs:2022/06/13
4.Year/Quarter of financial reports:The first quarter 2022
5.The extended deadline to announce financial reports
granted by the competent authority:2022/06/14
6.CPA audit (reviewed) opinion:Qualified Conclusion-Financial statements of
non-major subsidiary have not been reviewed.
7.The audited (reviewed) figures/self-assessed figures/difference
in monetary amount/ratio of discrepancy accumulated from
1/1 to end of the period of operating revenue (thousand NTD; %):
115,383/111,236/4,147/3.73%
8.The audited (reviewed) figures/self-assessed figures/
difference in monetary amount/ratio of discrepancy accumulated
from 1/1 to end of the period of operating gross profit (loss)
(thousand NTD; %):31,685/30,872/813/2.63%
9.The audited (reviewed) figures/self-assessed figures/
difference in monetary amount/ratio of discrepancy accumulated
from 1/1 to end of the period of net operating profit (loss)
(thousand NTD; %):(29,428)/(30,067)/639/-2.13%
10.The audited (reviewed) figures/self-assessed figures/
difference in monetary amount/ratio of discrepancy accumulated
from 1/1 to end of the period of net profit (loss) before tax
(thousand NTD; %):15,630/12,509/3,121/24.95%
11.The audited (reviewed) figures/self-assessed figures/
difference in monetary amount/ratio of discrepancy accumulated
from 1/1 to end of the period of net profit (loss) attributed
to the parent company (thousand NTD; %):12,488/11,958/530/4.43%
12.The audited (reviewed) figures/self-assessed figures/
difference in monetary amount/ratio of discrepancy
accumulated from 1/1 to end of the period of
earnings per share (loss) (NTD; %):0.06/0.06/0/0%
13.If there is a significant discrepancy between the audited
(reviewed) figures of financial reports reported to
or passed by the board of directors and the self-assessed
figures announced by the company, please explain the reasons
of discrepancies:Not applicable
14.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
Microtek International Inc. published this content on 13 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 June 2022 07:32:05 UTC.
Microtek International, Inc. is a Taiwan-based company principally engaged in the design, manufacture and sales of image scanners and its related applications. The Company operates through two segments. Image Scanners segment is engaged in the design, manufacture and sales of digital image input and output devices. Its products include image scanners for commercial use, for medical use, for biotechnical use and for industrial use, among others. Photoelectron Equipment segment is engaged in the research, manufacture and sales of optical passive devices, optical instrumentations and other photoelectron equipment. Through its subsidiaries, the Company is also involved in the sales of medical equipment, as well as the development and consultancy of related technologies.
MICROTEK INTERNATIONAL, INC. 
